By AssurX
In Medical Device Industry, FDA Regulated Industries, Pharmaceutical Industry, Quality Management, Regulatory Compliance Management
Posted Postmarket Surveillance is Most Effective when Approached as an Enterprise Interest
FDA regulation 21 part 822 lays out the process, the rules, and the products that require postmarket surveillance. The process is an active, systematic, scientifically valid method of [...]
![Visit AssurX at the ASQ World Conference on Quality & Improvement [Booth 406]](https://3fp7fz290dnz3qt1e1bh6k4v-wpengine.netdna-ssl.com/wp-content/uploads/2019/05/slider_convention-center-150x150.jpg)
